EB Grand China appoints Jiang Zhiwen as Executive Director, adds him to Nomination and Investment Committees

Bulletin Express
07/23

EB Grand China (Everbright Grand China Assets Limited) announced the appointment of Jiang Zhiwen as Executive Director, effective 23 July 2026. Jiang, aged 51, will also join the company’s Nomination Committee and Investment Committee.

Jiang brings more than two decades of policy research and administrative management experience. His prior roles include principal staff positions at the Development Research Center of the State Council (1998–2004) and successive leadership posts at the Liaison Office of the Central People’s Government in Hong Kong (2004–2022). From 2022 to 2026, he served as a level II bureau rank official and research fellow at the Mainland, Hong Kong and Macao Economic and Trade Exchange Promotion Association.

Under a three-year service agreement commencing 23 July 2026, Jiang will receive an annual salary of HK$0.87 million and a discretionary bonus determined by the Board and the Remuneration Committee. He holds no shares in EB Grand China under Part XV of Hong Kong’s Securities and Futures Ordinance.

Jiang currently serves as director or chairman of multiple EB Grand China subsidiaries, including Chengdu Everbright International Mansion Company Limited and Chengdu Everbright Finance Centre Development Company Limited. He is also a director of Capital Century Company Limited, the controlling shareholder of EB Grand China, and several of its subsidiaries.

Following the appointment, the Board comprises: • Executive Directors: Liu Jia (Chairman) and Jiang Zhiwen • Non-executive Directors: Zhuang Minrong and Yin Junyan • Independent Non-executive Directors: Ho Kwai Ching Mark, Shek Lai Him Abraham, Lee Jor Hung and Wang Cheung Yue

The Board noted that there are no other matters requiring shareholder attention under Listing Rule 13.51(2)(h)–(v).

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10